Vincerx

VINC42

Penny Stock

$0.25arrow_drop_down0.39%-$0.00

Penny Stock

VINC42

$0.25

arrow_drop_down0.39%-$0.00

Penny Stock

Performance History

Key Stats
Open	$0.25
Prev. Close	$0.25
EPS	-1.14
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$8.59M
PE Ratio	-

	LOW	HIGH
Day Range	0.25	0.27
52 Week Range	0.24	9.37

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.14

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Vincerx (VINC)

Vincerx, Inc. (VINC) is a biopharmaceutical company that is focused on developing innovative therapies for the treatment of cancer. The company's mission is to transform the lives of patients with cancer by targeting and eliminating the underlying drivers of the disease. Vincerx has a diverse pipeline of potential drug candidates, with a particular focus on targeting the immune system.

VINC stock has had a volatile price history since its initial public offering. The stock initially debuted at $15 per share, but quickly dropped to $10 per share in the first few months of trading. However, over the past year, the stock has seen a significant increase in value, reaching a high of $30 per share. This increase in value can be attributed to positive clinical trial results and increased investor optimism about the company's pipeline.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Ahmed M. Hamdy M.D.
Headquarters: Palo Alto
Employees: 41
Exchange: NASDAQ

Keep an eye on Vincerx

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Vincerx's (VINC) price per share?

The current price per share for Vincerx (VINC) is $0.26. The stock has seen a price change of -$0 recently, indicating a -0.39% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Vincerx (VINC)?

For Vincerx (VINC), the 52-week high is $9.37, which is 3.58K% from the current price. The 52-week low is $0.24, the current price is 4.51% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Vincerx (VINC) a growth stock?

Vincerx (VINC) has shown an average price growth of -3.72% over the past three years. It has received a score of 3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Vincerx as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Vincerx (VINC) stock price performance year to date (YTD)?

As of the latest data, Vincerx (VINC) has a year-to-date price change of -78.39%. Over the past month, the stock has experienced a price change of -31.54%. Over the last three months, the change has been -66.93%. Over the past six months, the figure is -61.31%.

help

Is Vincerx (VINC) a profitable company?

Vincerx (VINC) has a net income of -$40.16M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$42.61M. Furthermore, the EBITDA is -$27.41M.

help

What is the market capitalization of Vincerx (VINC)?

Vincerx (VINC) has a market capitalization of $8.59M. The average daily trading volume is 0.25, indicating the stock's liquidity and investor engagement.